The timelines for developing vaccines against infectious diseases are lengthy, and often
vaccines that reach the stage of large phase 3 field trials fail to provide the desired level of …

Typhoid fever control in the 21st century: where are we now? : Current Opinion in Infectious
Diseases Typhoid fever control in the 21st century: where are we now? : Current Opinion in …

Background: The Global Typhoid Genomics Consortium was established to bring together
the typhoid research community to aggregate and analyse Salmonella enterica serovar …

Typhoid fever is a significant global health problem that impacts people living in areas
without access to clean water and sanitation. However, collaborative international …

Objectives: In resource limited countries facing a huge burden of multidrug resistant and
extensively drug resistant (XDR) enteric fever, treatment is a great challenge on the part of a …

Typhoid-conjugate vaccines (TCVs) provide an opportunity to reduce the burden of typhoid
fever, caused by Salmonella Typhi, in endemic areas. As policymakers design vaccination …

(S. Typhi) caused an estimated 9.24 million cases (5.94 M, 14.1 M) of typhoid fever in 2019,
resulting in 110 000 deaths (52 800, 191 000)[1]. Over 4.8 million cases and 50 000 deaths …

Abstract The Global Typhoid Genomics Consortium was established to bring together the
typhoid research community to aggregate and analyse Salmonella enterica serovar Typhi …

Background Typhoid conjugate vaccines are available in the private market in India and are
also recommended by the National Technical Advisory Group on Immunisation (NTAGI) for …

Background India has a high typhoid fever burden. In 2022, the National Technical Advisory
Group on Immunisation recommended introducing typhoid conjugate vaccine (TCV) into the …